BioSpace News Archive

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the appointment of Michael Beaulieu as Vice President, Investor Relations and Corporate Communications.

TellBio, Inc., a development stage biotechnology company focused on revolutionizing the detection of cancer through its unique and proprietary circulating tumor cell (CTC) technology, TellDx, and treatment through its complementary therapeutics platform, TellRx, announces publication of data from the scientific founders that provide insights into mechanisms of PI3K/mTOR signaling in preclinical models of prostate cancer.

NuGen Medical Devices Inc. announces that it has agreed to settle an aggregate of $500,000 of indebtedness owed to an arm’s length creditor with respect to royalty payments due to the Creditor through the issuance of an aggregate of 1,644,736 common shares of the Company at a price of $0.304 per Common Share.

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions, declared a quarterly cash dividend of $0.38 per share.

Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces the completion of an additional $3 million funding agreement with Yorkville Advisors.

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, reports that the company mistakenly reissued the press release this afternoon entitled, “Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635.”

Taro Pharmaceutical Industries Ltd. announced that it plans to release its financial results for the quarter and nine months ended December 31, 2021, after the close of market on Thursday, January 27, 2022.

The global spine surgery products market is all set to gather noteworthy amounts in revenues in the forecast period of 2017 to 2025, states the recently published report by Transparency Market Research.

The global erythropoietin drugs market is prognosticated to demonstrate steady growth in coming years, as reported by Transparency Market Research.

Eargo, Inc., a medical device company on a mission to improve the quality of life of people with hearing loss, announced the submission of public comments to the Food and Drug Administration concerning its proposed rule to create a new regulatory category of over the counter hearing aids.